Innovation Spotlight: The Future of Business

After a brutal cold snap, Michiganders face huge energy bills. Consumers Energy is offering aid, but it highlights a growing crisis of affordability.

A $2.5B revitalization project enters a new phase, as Vornado and Newmark aim to transform a transit hub into NYC's premier 24/7 destination.

A new platform, Accelerated Clinical Trials (ACT), promises to slash drug development timelines by up to 20 months, but faces regulatory and ethical hurdles.

The medical tech firm has confirmed it's evaluating strategic options, including a non-binding offer from Steel Partners to acquire a 51% controlling stake.

A top industry award for Paytient highlights a growing shift: insurance isn't enough. See how flexible payments are redefining access to care.

Promising Phase 2 data for a potential first-in-class neuropathic corneal pain therapy to be showcased, offering new hope for a debilitating condition.

With stronger Phase 2 data for its ATH434 drug and a healthy cash reserve, Alterity Therapeutics is preparing for a pivotal trial and seeking partners.

Investors eye Rockwell Automation's upcoming conference for insights on its software growth, AI integration, and strategy for navigating economic headwinds.

The iconic restaurant chain joins America250 with new menu items and commemorative rockers, blending comfort food with a national celebration.

AI coding assistants are nearly universal, but a new report shows speed gains come with more security flaws, hidden costs, and a developer trust deficit.

Industry leaders at the GenScript Global Forum agree: the era of AI experimentation is over. Now, the hard work of scaling and building trust begins.

Unitil Corp. raises its dividend for the 11th consecutive year, a move backed by strong financials and a stable regulatory climate in New England.

As the food industry rushes to adopt natural colors, a regulatory gap emerges. Sensient's Certasure™ program aims to fill the void, ensuring safety.

Shipping giant CMA CGM and investment firm Stonepeak launch a joint venture, uniting 10 key global terminals to reshape supply chain control.

Alcami promotes a decade-long leader to COO, a strategic move to harness internal talent and manage its rapid growth in the booming CDMO market.

Projected to surpass $3.2 billion by 2032, the skin booster market is booming. Discover the science, business, and societal shifts driving this trend.

A new IAB study forecasts a robust 9.5% ad spend surge, driven by agentic AI, digital channel growth, and major events like the Olympics and World Cup.

Drowning in cryptic APIs? Salt Security's new AI instantly explains what any API does, bridging the skills gap and accelerating threat detection.

Enveric Biosciences raises $1.5M to advance its novel psychiatric drugs. Is this small cash infusion enough to propel its promising pipeline forward?

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.